CANbridge Pharmaceuticals Inc.

Canbridge pharmaceuticals inc. email format

Verified email-pattern data for Canbridge Pharmaceuticals Inc. is currently limited. You can still use the company insights and contact sections below.
CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region. CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to develop and commercialize proprietary therapeutics for the treatment of rare genetic diseases. In greater China, it has an exclusive licensing agreement to commercialize Hunterase®, an enzyme replacement therapy for the treatment of Hunter syndrome, developed by GC Pharma and marketed in more than ten countries worldwide. CANbridge also has an oncology portfolio, which includes exclusive rights to develop and commercialize Puma Biotechnology’s NERLYNX® (neratinib), in greater China, as well as rights to other novel candidates.

Company Details

Employees
49
Founded
-
Address
4 Burlington Woods Dr, Burlington,massachusetts 01803,united States
Industry
Pharmaceutical Manufacturing
HQ
Burlington, Massachusetts
Looking for a particular CANbridge Pharmaceuticals Inc. employee's phone or email?

Canbridge Pharmaceuticals Inc. Questions

Top CANbridge Pharmaceuticals Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant